Gladstone Institutes / October 11, 2021 / The race to develop drugs to treat Alzheimer’s disease, which currently affects an estimated 6 million Americans, has been slow-going. Now, researchers have found a possible treatment for the neurodegenerative disease in a surprising place: a database of drugs already approved by the US Food and Drug Administration (FDA).